Curious how Howie says they're funded through to revenue on SB, that's clearly not the case.
They're going to need a bucket of cash to commericalise SB, I'm reckoning on at least $20-$30m US to have any shot at material revenues.
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-96
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.010(2.60%) |
Mkt cap ! $714.9M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.5¢ | 37.5¢ | $4.833M | 12.29M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 511746 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 99994 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |